VC, Biotech, cancer

Catalyst Biosciences Raises $40M from Boston-Area Backers and Other Firms

Ryan McBride 12/4/08

Cambridge, MA-based venture firm HealthCare Ventures and several other backers have invested $40.4 million in a Series C round of financing for Catalyst Biosciences, a South San Francisco developer of protein-based drugs for diseases such as hemophilia and cancer, according to a company statement. Morgenthaler Ventures, a Menlo Park, CA-based firm which says it has a Boston office, and Novartis BioVentures, of Cambridge and Basel, Switzerland, are among the other firms that participated in the financing.

Ryan McBride is Xconomy's correspondent. You can reach him at rmcbride@xconomy.com, or follow him on Twitter at http://twitter.com/Ryan_McBride.